Skip to main content
Clinical Trials/JPRN-UMIN000017230
JPRN-UMIN000017230Recruiting未知

Correlation between efficacy of the biological therapy (tocilizumab) and levels of oxidative stress markers in Japanese patients with rheumatoid arthritis (inadequate responders to existing therapies) - Correlation between efficacy of the biological therapy (tocilizumab) and levels of oxidative stress markers in Japanese patients with rheumatoid arthritis (inadequate responders to existing therapies)

Kyushu University0 sites60 target enrollmentStarted: April 22, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)The patients have an obvious infection in by just before treatment administration, and research investigator or research sharing doctor has determined that they are inappropriate for this study. 2)Based on the Japan College of Rheumatology "tocilizumab use guidelines for rheumatoid arthritis (2012 Revised Edition)", the patients correspond to the administration contraindication 3)The Patients who were considered as inappropriate by the other research doctors based on the medical backgrounds. 4)Under 20 years old

Investigators

Similar Trials